ABSTRACT OBJECTIVES This study sought to investigate the characteristics of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation for femoropopliteal (FP) lesions, and to examine 1-year prognosis after repeat endovascular therapy (re-EVT) for these DES-ISR.
class I, focal lesions (#50 mm in length), class II, diffuse lesions (>50 mm in length), and class III, totally occluded ISR (7, 8) . Particularly, the prognosis of balloon angioplasty after post-BNS class III restenosis is direly poor, and the rates of repeat reintervention and conversion to bypass surgery are consequently high. However, there are no reports on the morphology of ISR after DES implantation. The aim of the current study was to investigate the characteristics of ISR after DES implantation for FP lesions, and to examine 1-year prognosis after repeated endovascular therapy (re-EVT) for these DES-ISR lesions.
METHODS STUDY POPULATION AND DEFINITIONS.
This was a subanalysis of the ZEPHYR (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery) study.
The ZEPHYR study was a prospective multicenter study enrolling patients with femoropopliteal lesions undergoing Zilver PTX implantation between July 2012 and April 2013. The details of the study protocol and the 1-year results were described elsewhere (9) .
The study was in accordance with the Declaration of 
Characteristics and Re-EVT of DES-ISR in FP Lesions stenosis) was calculated as: P MALE þ (1 À P MALE ) Â P Restenosis , in accordance with the previous report Table 1 shows the baseline characteristics at DES implantation of the study population. The mean age of the study population was 73 AE 9 years, and 67% (141 of 210) were male. The prevalence of critical limb ischemia was 25% (n ¼ 58), and average lesion length was 18 AE 9 cm. IVUS-evaluated EEM area and MSA were 25 AE 9 mm 2 and 14 AE 4 mm 2 , respectively. In the 210 cases with loss of patency 1 year after DES implantation, the proportion of classes I, II, and III Iida et al.
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A P R I L 2 5 , 2 0 1 6 : 8 2 8 -3 4 was 50% (n ¼ 106), 25% (n ¼ 52), and 25% (n ¼ 52), respectively ( Figure 2) . The comparison in background characteristics at DES implantation among the restenotic classes are shown in Table 2 . This univariate analysis showed that chronic total occlusion (CTO) and IVUS-evaluated EEM area were significantly associated with the morphology of DES-ISR. We subsequently tried multivariate analysis ( Table 3 ), indicating that CTO and EEM area, but not diabetes mellitus (DM), were independently associated with DES-ISR classes.
As shown in Table 4 , the treatment strategy for DES-ISR were not significantly different among the DES-ISR classes; approximately two-thirds underwent re-EVT. Figure 3 shows 1-year restenosis rate after re-EVT for loss of patency. One-year incidence of restenosis in classes I, II, and III was estimated to be 53% (95% CI: 39% to 67%), 74% (58% to 90%), and 78% (16 to 94%), whereas 1-year MALE was observed in 32% (20% to 45%), 56% (39% to 73%), and 56% (41% to Abbreviations as in Table 1 . Values are odds ratios adjusted for chronic total occlusion and IVUS-evaluated EEM area, derived from the ordinal logistic mixed model with intersubject variability treated as random effects. Note that the adjusted odds ratios of chronic total occlusion and EEM area were obtained from the ordinal logistic mixed model whose fixed effects were the 2 variables, whereas those of the other variables were obtained from the model whose fixed effects were the variable of interest plus chronic total occlusion and EEM area (3 variables in total).
CI ¼ confidence interval; ISR ¼ in-stent restenosis; other abbreviations as in Table 1 . However, because the current sample size was small, the current findings regarding these independent associations may be inconclusive. Future studies with a larger sample size are needed to confirm these findings.
INTERPRETATIONS OF THE CURRENT FINDINGS.
Zilver PTX is the only available drug-eluting stent for treating peripheral artery disease patients presenting Error bars indicate 95% CI. One-year incidence of restenosis in classes I, II, and III was estimated to be 53% (95% CI: 39% to 67%), 74% (58% to 90%), and 78% (16% to 94%), whereas 1-year MALE was observed in 32% (20% to 45%), 56% (39% to 73%), and 56% 
Values are n (%).
Re-EVT ¼ repeat endovascular therapy. study population, the absolute incidence rates of them were not low at all. These high rates may come from the fact that the target lesions were so complicated in the current study. CLINICAL IMPLICATION. To the best of our knowledge, this is the first study evaluating the characteristics of DES-ISR, and 1-year results after re-EVT for these lesions. In the current situation, DES is reliable and promising devices in reducing the restenosis rate for FP lesions, and will be more frequently used in the clinical setting. Consequently, it is speculated that the number of DES-ISR simultaneously will increase with its use. Therefore, our finding will be clinically meaningful and helpful in considering the indication for endovascular revascularization, because it may inform the decision-making process for FP revascularization.
STUDY LIMITATIONS. First, in the current study, the assessment for recurrent DES-ISR was not conducted under core laboratory review, simply because of insufficient research funds for conducting it. As mentioned in initial report of the ZEPHYR study, each participating site has clinical experience conducting pivotal trials on nitinol stents for FP lesions. We believe that these accumulated experiences minimized the variability. Second, the number of DES-ISR might be relatively small. However, the number was similar to that of recent studies on BNS-ISR, indicating the current study would have a similar statistical power compared with them. Third, we only assessed 1-year prognosis after re-EVT for DES-ISR.
Further investigation of long-term follow-up will be needed to assess the consequence of re-EVT for DES-ISR.
CONCLUSIONS
We evaluated the characteristics of ISR after DES Japan. E-mail: iida.osa@gmail.com.
